This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
-
Ralph Mendoza, North American Sales Manager, Klöckner Pentaplast of America
-
Justin Schroeder, Executive Director, Marketing, Business Development & Design at PCI
-
John Steenkamer, Business Manager, Pharmaceutical, Constantia Flexibles
-
Melissa Green, Global Strategic Marketing Manager for the Healthcare Business, Honeywell
-
Matt Rayner, Executive Director of Operations, Legacy Pharmaceutical Packaging
-
Tom McDonough, Executive Vice President, America's, Bilcare Research, Inc.
-
John Grinnell, Vice President and Managing Director for MWV Healthcare’s Secondary & Adherence Packaging Division
-
Bill Sharpless, Business Development Manager, Healthcare Packaging, Winpak
-
Joe Luke, Vice President of Sales & Marketing, Reed-Lane
“We are excited to have the guidance and commitment of these esteemed pharmaceutical packaging representatives as we enter into our 25th Anniversary year,” stated Walt Berghahn, HCPC Executive Director, “particularly as we embark on publishing our latest research, The HCPC Prescription Packaging In-Use Study.” This study, started in late 2013, involved all board members. The purpose was to bring awareness to the fact that high barrier unit dose packaging protects individual doses better than commonly used pharmaceutical prescription packaging, particularly when these packages are subjected to typical at-home use by patients. Within the context of the study, the organization understands that manufacturers are within the regulated requirements regarding package stability but, due to antiquated dispensing methods and subsequent repackaging before patient use, there may be an impact on product quality and potential efficacy. The HCPC supports the further validation of its findings, by either regulatory or experienced industry research organizations. We thank our board for their guidance during the undertaking of this intense research. The HCPC looks forward to sharing the study results and creating awareness that non-coated drug tablets dispensed in packaging with minimal moisture and oxygen protection have an increased risk of physical degradation during normal use, i.e., daily exposure to the home environment. (The HCPC Prescription Packaging In-Use Study can be downloaded by visiting www.hpconline.org.)
